Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
BMJ Open|April 7, 2025
Effectiveness and cost-effectiveness of a home-based functional exercise programme for community-dwelling frail older adults, ACTIVE-AGE@home, provided by professionals and volunteers: protocol of a pragmatic randomised controlled trialDimitri Vrancken, Elke De Smedt, Jade Tambeur, et al.
Clinical Kidney Journal|July 5, 2021
Fighting the unbearable lightness of neglecting kidney health: the decade of the kidneyRaymond Vanholder, Lieven Annemans, Aminu K Bello, et al.
Kidney International. Supplement|December 23, 2004
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuriaAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.
Ageing Research Reviews|September 7, 2025
Unravelling the miscellaneous effects of exercise interventions on activities of daily living in frail older adults: A systematic review and meta-analysisEmma De Keyser, Jade Tambeur, Elke De Smedt, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 9, 2021
Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visitsRuben Willems, Fouke Ombelet, Eva Goossens, et al.
Human Reproduction (Oxford, England)|July 5, 2014
Self-operated endovaginal telemonitoring versus traditional monitoring of ovarian stimulation in assisted reproduction: an RCTJan Gerris, Annick Delvigne, Nathalie Dhont, et al.
The Lancet. Digital Health|February 24, 2023
Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trialsGeorge Moschonis, George Siopis, Jenny Jung, et al.
Clinical Therapeutics|August 30, 2003
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathyRoger A Rodby, Chion Fang Chiou, Jeff Borenstein, et al.
The Lancet. Digital Health|February 24, 2023
Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trialsGeorge Siopis, George Moschonis, Evette Eweka, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest groupEric Faulkner, Lieven Annemans, Lou Garrison, et al.
Pageof 27